Test of Pro-Adrenomedullin for diagnosing acute appendicitis in adults
Official title: Prospective Comparison of the Diagnostic Accuracy of Pro-Adrenomedullin, C-Reactive Protein, and Neutrophil-to-Lymphocyte Ratio in Acute Appendicitis
Run by Bursa Yuksek Ihtisas Training and Research Hospital · NCT07889544 · Data updated 2026-11-12
We are testing whether Pro-Adrenomedullin can help diagnose acute appendicitis in adults and how it compares to CRP and NLR.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 400 (estimated) |
| Sponsor | Bursa Yuksek Ihtisas Training and Research Hospital Government |
| Locations | 1 site (Bursa) |
| Status | Recruiting |
| Started | August 1, 2026 |
| Main results expected | August 1, 2027 |
| Study ends | August 1, 2027 |
| Registry record updated | October 26, 2026 |
| Trial ID | NCT07889544 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–90 presenting with suspected acute appendicitis and adults without abdominal pain or active inflammatory disease serving as controls.
✕Probably not a fit
Patients with non-inflammatory abdominal conditions or conditions affecting Pro-ADM could see limited or no diagnostic benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, observational study at a single center enrolling up to 400 adults (18–90) undergoing appendectomy for acute appendicitis and healthy controls. The study measures Pro-Adrenomedullin levels in blood and compares them with standard inflammatory biomarkers (CRP, NLR) and routine diagnostics. It aims to see how well Pro-ADM distinguishes appendicitis from health and whether it predicts complicated disease. Data collected include medical history, clinical findings, imaging, and laboratory tests. Participants provide informed consent and undergo blood sampling for Pro-ADM along with standard labs.
Why it matters
Potential benefit: If successful, Pro-ADM testing could improve diagnostic accuracy and help identify complicated appendicitis earlier.
How similar studies have gone: Previous research suggests Pro-ADM may be useful in other inflammatory infections, but evidence in adult acute appendicitis is limited and this study adds new data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adults aged 18 to 90 years. 2. Patients presenting to the emergency department within 48 hours of the onset of abdominal pain, either directly or following referral from another healthcare institution with a diagnosis or suspicion of acute appendicitis. 3. Patients undergoing appendectomy for acute appendicitis (acute appendicitis group). 4. Individuals attending outpatient clinics for routine health evaluations without abdominal pain or active inflammatory disease (control group). 5. Provision of informed consent for participation in the study. Exclusion Criteria: 1. Age younger than 18 years or older than 90 years. 2. Use of antibiotics or systemic corticosteroids within the preceding month. 3. Active malignancy. 4. Immunosuppressive disease or ongoing immunosuppressive treatment. 5. Abdominal surgery within the preceding three months. 6. Heart failure, renal failure, or liver cirrhosis. 7. Pregnancy or postpartum period. 8. Inability to provide informed consent due to psychiatric disorders.
Where it's running
-
Bursa Yuksek Ihtisas Training and Research Hospital
Bursa, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Ugur Duman, MD — University of Health Sciences Turkiye, Bursa Yuksek Ihtisas Training and Research Hospital
- Study coordinator: Ugur Duman, MD
- Email: ugur.duman@sbu.edu.tr
- Phone: +905458177971
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Inflammatory biomarkers in blood and appendix tissue in acute appendicitis
This study tests whether blood and appendix tissue biomarkers correlate with how severe a patient’s acute appendicitis is, to help distinguish uncomplicated from complicated cases.
-
Pediatric ERAS-Adapted Laparoscopic Appendectomy Feasibility
This study tests a 20-item enhanced recovery protocol in children aged 5–18 undergoing laparoscopic appendectomy to see if it can be safely and reliably applied in a real clinical setting.
-
Comparing CT scan reports and the AIR score in adults having an appendectomy for suspected appendicitis.
This will try to see if CT scan reports and the Appendicitis Inflammatory Response (AIR) score can accurately identify true appendicitis in adults who have an appendectomy after a CT suggests appendicitis.
-
Urinary PGE-M to help predict acute appendicitis in children
We will test whether a urine marker called PGE-M can help diagnose acute appendicitis in children ages 5 to 17 who come in with sudden belly pain.
-
Using AI to train doctors in pediatric care
This study is testing whether using virtual patients powered by AI can help train doctors in China to better care for children with common health issues.
-
Using magnesium sulfate to reduce opioid use in children having laparoscopic appendectomy
This study tests if giving magnesium sulfate through an IV can help reduce the amount of opioids kids need during laparoscopic appendectomy surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.